Desloratadine clarinex manufacturing plant project report?

Desloratadine (Clarinex) Manufacturing Plant Project Report

Information regarding a specific "Desloratadine Clarinex manufacturing plant project report" is not publicly available. Manufacturing plants and their associated project reports are typically proprietary to pharmaceutical companies.

What is Desloratadine?

Desloratadine is a second-generation antihistamine used to treat allergies. It is the active metabolite of loratadine and works by blocking histamine, a substance in the body that causes allergic symptoms [1]. It is marketed under various brand names, including Clarinex [2].

How does Desloratadine work?

Desloratadine functions as a selective peripheral H1-receptor antagonist. By binding to these receptors, it prevents histamine from triggering allergic reactions, thereby alleviating symptoms such as sneezing, runny nose, itchy eyes, and hives [1].

When does Desloratadine patent protection expire?

The patent expiration timeline for desloratadine and its associated products like Clarinex can be complex, involving multiple patents for the compound itself, its manufacturing processes, and formulations. Information on specific patent expirations is typically tracked by specialized services. For detailed patent status, DrugPatentWatch.com can be a resource [3].

Who manufactures Desloratadine?

Several pharmaceutical companies manufacture desloratadine, both as branded products and as generic alternatives. The original developer of Clarinex was Schering-Plough, which was later acquired by Merck & Co. [4]. Generic versions are produced by numerous companies worldwide.

What are the regulatory approvals for Desloratadine?

Desloratadine has received regulatory approval from agencies such as the U.S. Food and Drug Administration (FDA) for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria [1].

What is the difference between Desloratadine and Loratadine?

Desloratadine is the primary active metabolite of loratadine. This means that after loratadine is ingested, the body metabolizes it into desloratadine to exert its antihistamine effect. Desloratadine is considered to be more potent and faster-acting than loratadine because it bypasses the metabolic conversion step [1].

Sources:

[1] Desloratadine - National Library of Medicine
[2] Clarinex - Drugs.com
[3] DrugPatentWatch.com
[4] Merck Acquires Schering-Plough - Merck (press release)